期刊
BIOSENSORS & BIOELECTRONICS
卷 195, 期 -, 页码 -出版社
ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2021.113654
关键词
Nanoassenbly; pH-response; Tumor detection; Enzymatic therapy; Chemotherapy
类别
资金
- NSFC [91953105, 21775041]
- Natural ScienceFoundation of Hunan Province [2019JJ50368, 2019JJ50134]
The novel cancer theragnostic nanoassembly developed has high biocompatibility, stability, and low toxicity, and can be rapidly activated by the tumor microenvironment for selective fluorescence imaging, chemotherapy, and chemoenzymatic therapy. It shows great potential in cancer diagnosis and efficient therapy.
We have developed a novel cancer theragnostic nanoassembly with high biocompatibility, stability and low toxicity which are activated rapidly by tumor microenvironment to realize selective fluorescence imaging, chemotherapy as well as chemoenzymatic therapy. The nanoprobes are synthesized by hybridization of fluo-rophore labeled hairpin DNAs containing a 5-aza-dC at hemimethylated CpG sites and pH-sensitive DNA sequence covalently conjugated with PEGylated GO. The aptamer, which is also covalently conjugated on PEGylated GO, enables to target the tumor site and the weak acid environment of tumor triggers the release of drug loaded by nanoprobes including functionalized DNA and DOXs, effectively activating fluorescence signals and selectively killing the tumor cells. The results revealed that the nanoprobe enables sensitive detection of pH changes within subcellular environment, selectively imaging and great synergy of multicombination therapeutic including chemotherapy and chemoenzymatic therapy, implying that developed pH activatable probe has considerable potential for diagnosis and efficient therapy of cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据